scorecardresearch
Tuesday, August 12, 2025
TopicCentral Drugs Standard Control Organization

Topic: Central Drugs Standard Control Organization

Drug regulator’s latest guidelines on recall lack teeth, legal backing, have too many ‘loopholes’

Public health activists say unless drug recall policy with legal backing is brought in, guidelines will not serve any purpose; ask who has ultimate authority to verify all batches are recalled.

India denies nod to ‘1st-ever weekly insulin’ for diabetics, seeks more info from maker Novo Nordisk

Icodec has been touted as a therapy that could eliminate the need for daily or mealtime insulin injections for people with severe diabetes. It has not been approved by any country so far.

Global pharma majors pitch for faster approval of innovative drugs in India but CDSCO remains cautious

Organisation of Pharmaceutical Producers of India seeks nod for drugs to be marketed at same time as US, Europe. But regulator rarely permits a drug launch without local clinical trials.

Drug regulator initiates move to control tapentadol & pregabalin sale amid reports of growing misuse

India's apex drug regulator will form a panel to examine whether more regulatory restrictions should be put in place. Experts say more curbs a good idea but implementation is key.

2 cough syrups found ‘contaminated’, regulator launches probe into Gujarat drugmaker

CDSCO says two cough syrups manufactured by Ankleshwar-based Norris Pharma were found to contain Ethylene Glycol (EG) & Diethylene Glycol (DEG) beyond acceptable limits.

Drugs regulator to probe ‘faulty’ optical lens by Swiss-American firm Alcon

The Central Drugs Standard Control Organisation has formed an inquiry committee following a complaint by ophthalmologist and ex-parliamentarian Dr Vikas Mahatme.

CDSCO probing cough syrups made by Haryana firm that ’caused 66 kids’ deaths in The Gambia’

WHO alerted Indian authorities of possible link between the deaths and four cough and cold medicines made by Sonepat-based Maiden Pharmaceuticals on 29 September, it is learnt.

Pune cell science centre could soon get Modi govt nod to test and approve Covid vaccines

If given a go-ahead, National Centre for Cell Science will be the 2nd centre after Central Drugs Laboratory, Kasauli, to test Covid-19 vaccines.

Roche India gets nod for emergency use of Casirivimab, Imdevimab for Covid treatment

The antibody cocktail is to be used for the treatment of mild to moderate Covid in adults and pediatric patients with a high risk of severe symptoms, Roche said in a statement.

Why India’s expert panel rejected Pfizer plea for emergency use nod to its Covid vaccine

The Drug Controller General of India has in the past rejected several applications from other drugmakers, including Dr Reddy Laboratory and Natco Pharma.

On Camera

Munir wants Pakistan military to be taken seriously. He was impressing Imran’s supporters

Operation Sindhoor came as a blessing for Asim Munir. He could claim to have “won a war” and get promoted to a field marshal’s post. But the narrative hasn’t held.

How mining, manufacturing & power sectors weighed on India’s industrial output since January 2024

India’s industrial output growth saw a 10-month low in June, with Index of Industrial Production (IIP) growing by mere 1.5% as against 1.9% in May 2025.

Can’t restrict ‘extent of induction’—why SC struck down gender quotas in Army’s JAG recruitment

New Delhi: The Supreme Court has ruled that the Indian Army cannot cap the number of women in its Judge Advocate General (JAG) branch...

Modi’s ready to risk it all for farmers. Farm reform can answer Trump with new Green Revolution

Standing up to America is usually not a personal risk for a leader in India. Any suggestions of foreign pressure unites India behind who they see as leading them in that fight.